Your donation will make a difference:
Cystic Fibrosis Trust

UKCFC 2017 video gallery

Watch the presentations from the UK Cystic Fibrosis Conference.

Day 1, session 1, talk 1: Welcome and conference introduction

07 September 2017

Welcome and conference introduction from George Jenkins, Chair of Trustees at the Cystic Fibrosis Trust, and David Ramsden, CEO at the Trust.

Day 1, session 1, talk 2 and 3: the role of CFTR and Airway Surface Liquid (ASL) interface

07 September 2017

'Understanding how CFTR keeps the lungs healthy and what to do about it when it doesn’t work' – David Sheppard, Professor of Physiology at the University of Bristol, followed by 'The importance of Airway Surface Liquid (ASL) interface, volume and pH' - Robert Tarran, Associate Professor of Cell Biology and Physiology at the University of North Carolina.

Day 1, session 1, talk 3: Visualising the cilia

07 September 2017

Visualising the cilia - Dr Pietro Cicuta, Head of Biological and Soft Systems at Cavendish Laboratory, University of Cambridge.

Day 1, session 1, talk 4: Can we target other ion channels?

07 September 2017

Targeting non-CFTR ion channels that could offer opportunities for new CF therapies - Dr Michael Gray, Cellular Physiology, University of Newcastle

Day 1, session 1, talk 5: 'Hot off the press' - Targeting other channels involved in ASL

07 September 2017

Targeting other channels involved in ASL and using bronchospheres to screen for compounds that influence ASL - Dr Henry Danahay, Head of Biology at Enterprise Therapeutics.

Day 1, session 2, introduction and talk 1: Mucus

07 September 2017

Introductory chair scene setting (five minutes) by David Thornton, Professor of Biochemistry, University of Manchester, followed by Anna Ermund, Medical Biochemistry and Cell Biology at the University of Gothernburg, presenting on how ion channel dysfunction affects mucus in the lung.

Day 1, session 2, talks 2: 'Hot off the press' - A novel approach to treating mucus dysfunction

07 September 2017

‘Hot off the press’ - OligoG: A novel approach to treating mucus dysfunction, Phase 2b results and plans for the future - Astrid Hilde Myrset, Director for Pre-Clinical and Clinical Research at AlgiPharma.

Day 1, session 3, talk 1: Pulmonary infection by Pseudomonas aeruginosa

07 September 2017

Pulmonary infection by Pseudomonas aeruginosa and the case for new antimicrobials - Jane Davies, Professor in Paediatric Respirology, Imperial College London and Royal Brompton Hospital.

Day 1, session 3, talk 2: Why is it so hard to find new antibiotics?

07 September 2017

Review on Antimicrobial Resistance and addressing the global economic challenges of developing new antibiotics – William Hall, previously Senior Policy Adviser on the Review into Antimicrobial Resistance.

Day 1, session 3, talk 3: A novel therapeutic approach to resolve inflammation in CF

07 September 2017

A novel therapeutic approach to resolve inflammation in CF and results from a Phase 2 study - Barbara White, MD Chief Medical Officer at Corbus Pharmaceuticals, Inc.

Day 1, session 3, talk 4: What happens if we correct CFTR?

07 September 2017

Correcting CFTR, long-term follow up data on the use of ivacaftor - Stuart Elborn, Professor of Respiratory Medicine, Imperial College London and Royal Brompton Hospital.

Day 2, session 1, talk 1: Clinical trials: where are we now?

07 September 2017

Clinical trials: where are we now? - Dr Damian Downey, Consultant Respiratory Physician at Queens University Belfast.

Day 2, session 1, talk 2: Future CF therapies depend on all of us

07 September 2017

Keynote - The role of the Trials Development Network in coordinating CF trials in the USA, the increased number of trials and finding better outcome measures that reflect patient need - George Retsch-Bogart, University of North Carolina and Cystic Fibrosis Foundation Trials Development Network.

Day 2, session 1, talk 3: Clinical Trials Accelerator Platform

07 September 2017

Increasing capacity for clinical trials in the UK through the Clinical Trials Accelerator Platform - Keith Brownlee, Director of Impact at the Cystic Fibrosis Trust.

Day 2, session 2, talk 1: Clinical trials forum: families, carers and people with CF perspectives

07 September 2017

Forum - What are the experiences of people who have taken part in cystic fibrosis clinical trials? - Katie Gathercole and Zoe Elliott.

Day 2, session 2, talk 2: Clinical trial challenges in the age of personalised medicine: industry perspective

07 September 2017

The challenges of clinical trials in the age of personalised medicine, an industry perspective - David Geller, Medical Director CF at Abbvie.

Day 2, session 3: The Cystic Fibrosis Trust: a year in the life

07 September 2017

A year in the life of the Cystic Fibrosis Trust - meet the CEO, with updates on the UK CF Registry, research, fundraising, policy, volunteering and future plans - Oli Lewington, Director of Engagement, and David Ramsden, Chief Executive.

Day 1, sponsor lunchtime symposium: 'Beyond the lung - will Cinderella go to the ball?'

07 September 2017

Sponsor Lunchtime Symposium - ‘Beyond the Lung’ - Vertex

Day 2, session 4, workshop A: Clinical Psychology

07 September 2017

Workshop A: clinical psychology – the science of psychology and the thriving child and adolescent - Dr James Lemon, Consultant Clinical Psychologist, NHS

Day 2, session 4, workshop B: Nutrition

07 September 2017

Workshop B: Nutrition - practical ways of monitoring nutritional status in cystic fibrosis - Darren Sills, Lead Adult Cystic Fibrosis Dietician, Wolfson Adult CF Unit, Nottingham University Hospital Trust

Day 2, session 4, workshop C: Physiotherapy

07 September 2017

Workshop C: Physiotherapy - clinical exercise testing and prescription - Professor Craig Williams, Director at the Children’s Health and Exercise Research Centre, University of Exeter

Day 2, session 4, workshop D: Pharmacy

07 September 2017

Workshop D: Pharmacy - access to new medicines, pipelines to patients - Patrick Wilson, Assistant Head of Pharmacy at Clinical and Operational Services Pharmacy Department, Nottingham University Hospitals

CF's Got Talent

12 September 2017

Roger Black hosts our competition for early career researchers in cystic fibrosis to present their work to a lay audience. Watch all of the presentations and find out who this year's winner is!


07 September 2017

Hear from cystic fibrosis Clinical Nurse Specialist Jacqui Cowlard on just exactly what cross-infection means to people with CF and their friends and families.

Gene mutations

07 September 2017

F508del? W1282X? We explain the different CF-causing mutations of the gene that makes the CFTR protein, and why drugs like Orkambi and Kalydeco work.

The A-Z of cystic fibrosis

07 September 2017

We spoke to kids with cystic fibrosis to find out what their CF means to them - check out their answers!

What is cystic fibrosis?

07 September 2017

So what is CF, exactly? Youtuber Charles Michael Duke breaks it down!

Research we fund

We fund research to tackle some of the most pressing issues in CF today. Find out how your donations are making a difference.

What is CF?

Cystic fibrosis, or CF, affects the lungs, digestive system and other organs, and there are over 10,600 people living with it in the UK.

Contact us

Get in touch with us to speak to someone on our Helpline, find out about an event or speak to our Press Team.